CNBCPfizer's CEO says Covid vaccine effectiveness drops to 84% after six monthsJul 28, 2021Kevin StankiewiczBy Kevin Stankiewiczmore_vert
US Embassy in Thailand - USEmbassy.gov1.5 Million Pfizer Vaccine Doses, Donated by the United States, Arrive in ThailandJul 30, 2021more_vert
ForbesWhy Hasn't The FDA Fully Approved Any Covid-19 Vaccines Yet?Jul 30, 2021Katie JenningsBy Katie Jenningsmore_vert
The Washington PostFDA asks Pfizer, Moderna to test their vaccines in more children to help rule out safety issuesJul 26, 2021Laurie McGinley, Carolyn Johnson & Yasmeen AbutalebBy Laurie McGinley, Carolyn Johnson & Yasmeen Abutalebmore_vert
The New York TimesCiting New Data, Pfizer Outlines Case for Booster Shots (Published 2021)Sep 13, 2021Apoorva Mandavilli, Sharon LaFraniere & Carl ZimmerBy Apoorva Mandavilli, Sharon LaFraniere & Carl Zimmermore_vert
The GuardianCovid poses higher risk of myocarditis than vaccine in male teens – US studyJul 29, 2021Natalie GroverBy Natalie Grovermore_vert
CNBCModerna says it plans to expand Covid vaccine trial for kids 5 to 11, will seek FDA OK as early as year-endJul 26, 2021Berkeley Lovelace & Berkeley Lovelace Jr.By Berkeley Lovelace & Berkeley Lovelace Jr.more_vert
BloombergPfizer (PFE) Expects Covid-19 Vaccine Sales to Top $33 Billion This YearJul 28, 2021Riley GriffinBy Riley Griffinmore_vert
The Wall Street JournalAstraZeneca Loses Money on Covid-19 Vaccine for Second Straight QuarterJul 29, 2021Cecilia Butini & Jenny StrasburgBy Cecilia Butini & Jenny Strasburgmore_vert
CNNPfizer data suggest third dose of Covid-19 vaccine 'strongly' boosts protection against Delta variantJul 28, 2021Jacqueline HowardBy Jacqueline Howardmore_vert
ReliefWebThe great vaccine robbery: Pharmaceutical corporations charge excessive prices for COVID-19 vaccines while rich ...Jul 29, 2021more_vert
FiercePharmaPfizer now expects COVID vaccine sales to reach $33.5B this year, a whopping $7.5B bump from its estimate 3 months ...Jul 28, 2021Kevin DunleavyBy Kevin Dunleavymore_vert
The Wall Street JournalIsrael Begins Pfizer Covid-19 Vaccine for At-Risk Children Under 12 as Delta Cases SurgeJul 27, 2021Rory Jones & Dov LieberBy Rory Jones & Dov Liebermore_vert
ReutersModerna says COVID-19 vaccine supply outside United States to slow downJul 27, 2021Sangmi ChaBy Sangmi Chamore_vert
ReutersEXCLUSIVE AstraZeneca exploring options for COVID-19 vaccine business - executiveJul 29, 2021Pushkala Aripaka & Alistair SmoutBy Pushkala Aripaka & Alistair Smoutmore_vert
The New York TimesVaccine Makers Are Asked to Expand Safety Studies on Children (Published 2021)Aug 5, 2021Sharon LaFraniere, Sheryl Gay Stolberg & Noah Mercer WeilandBy Sharon LaFraniere, Sheryl Gay Stolberg & Noah Mercer Weilandmore_vert
The New York TimesPfizer and Moderna Are Expanding Vaccine Studies of Kids 5 to 11Nov 1, 2021Sharon LaFraniere, Sheryl Gay Stolberg & Noah Mercer WeilandBy Sharon LaFraniere, Sheryl Gay Stolberg & Noah Mercer Weilandmore_vert
The GuardianAstraZeneca sales of Covid vaccine triple to $1.2bn in first half of 2021Jul 29, 2021Julia KolleweBy Julia Kollewemore_vert
ForbesPfizer Expects $33.5 Billion In Vaccine Revenue In 2021Jul 28, 2021Aayushi PratapBy Aayushi Pratapmore_vert